Related Experiment Video
Updated: Mar 9, 2026

07:02
Animal Model of Implant-Associated Infections in Mice
Published on: June 27, 2025
1.1K
Active and Passive Immunization Against Staphylococcus aureus Periprosthetic Osteomyelitis in Rats
Niels H Søe1, Nina Vendel Jensen2, Asger Lundorff Jensen3
1Hand Section, Department of Orthopaedics, Herlev and Gentofte University Hospital, Hellerup, Denmark Niels.Soee.Nielsen@regionh.dk.
In Vivo (Athens, Greece)
|January 9, 2017
Summary
Active immunization against polysaccharide poly-N-acetylglucosamine (PNAG) reduced Staphylococcus aureus osteomyelitis in rats. Passive immunization showed broader, but less specific, protection against S. aureus implant infections.
Area of Science:
- Orthopedic surgery
- Infectious disease
- Immunology
Background:
- Staphylococcus aureus infections pose challenges in orthopedic implant settings.
- Developing effective immune responses against implant-related osteomyelitis is crucial.
- Current treatments for implant-associated S. aureus infections are limited.
Purpose of the Study:
- To investigate the efficacy of active and passive immunization strategies against Staphylococcus aureus osteomyelitis in a rat knee prosthesis model.
- To explore the potential of targeting polysaccharide poly-N-acetylglucosamine (PNAG) for immune intervention.
Main Methods:
- A rat knee prosthesis model was established with Staphylococcus aureus (S. aureus) induced osteomyelitis.
- Fifty-two rats were divided into active immunization (synthetic PNAG) and passive immunization (S. aureus immunoglobulin) groups.
- Bacterial inoculum and knee prosthesis were introduced into the tibia and femur marrow.
Main Results:
- Active immunization targeting PNAG significantly reduced osteomyelitis caused by PNAG-producing S. aureus (ica+).
- Active immunization was ineffective against S. aureus strains lacking PNAG production (ica-).
- Passive immunization provided clinical improvements for both ica+ and ica- S. aureus challenges, indicating broader but less specific activity.
Conclusions:
- Active immunization against PNAG shows promise for specific S. aureus implant infections.
- Passive immunization offers a broader, albeit less specific, therapeutic avenue for S. aureus osteomyelitis.
- Further research is needed to optimize immunotherapeutic strategies for implant-associated S. aureus infections.

